Pamela J. Gentry’s Post

💊 Understanding Prescription Drug Coverage and CleverRx 💊 Did you know that not all medications are covered under prescription drug plans, whether they are stand-alone Part D or included in your Advantage plans? It can be frustrating to find out a needed drug isn’t covered. That's where I come in! I help my clients afford their medications with CleverRx, a fantastic service that offers discounts on prescriptions. Want to learn more about how CleverRx can help you save? Check it out here: https://zurl.co/9Rql #PrescriptionSavings #CleverRx #AgentBenji #MedicareHelp #AffordableMedication

You CAN use GoodRx while on Medicare. We’ll show you how, as well as several other ways to get prescription drug pricing. https://lnkd.in/g9fYiHFt #medicaremindset #medicare #goodrx

Why You Need to Understand Medicare Part D Prescription Tiers Understanding Medicare Part D prescription drug formulary tiers is crucial for managing your prescription drug coverage. Learn more about how these tiers work and how they can affect your out-of-pocket costs. If you're looking for information on prescription drugs and Medicare coverage, this video is a must-watch! #MedicarePartD #Medicare

GLP-1 medications have been a tipping point in exposing the role that PBM’s have over controlling prescription drug access and cost. Register; https://lnkd.in/gK-t3mq6 for our next episode of The Pulse as we uncover the role of the PBM in prescription drug access and costs and what employers need to do to redefine expectations and outcomes from PBMs. Speakers include: Ge Bai, Jonathan Bonnet, MD, MPH, Jennifer Perlitch  #dataanalytics #glp-1 #employeebenefits 

GLP-1 medications have been a tipping point in exposing the role that PBM’s have over controlling prescription drug access and cost. Register https://lnkd.in/gK-t3mq6 for our next episode of The Pulse as we uncover the role of the PBM in prescription drug access and costs and what employers need to do to redefine expectations and outcomes from PBMs. Speakers include: Ge Bai, Jonathan Bonnet, MD, MPH, and Jennifer Perlitch  #dataanalytics #glp-1 #employeebenefits 

It’s the time of year again to clean out those medicine cabinets. Read our short post here about DEA’s National Prescription Drug Take Back Day. https://lnkd.in/eM2zUxNT #fda #thefdalawblog

As a result of the changes to Medicare Part D under §11201 of the Inflation Reduction Act of 2022, on April 1, 2024, CMS released Final Redesign Program Instructions (“Final Program Instructions”) for the Medicare Part D prescription drug program which are effective starting in 2025.  To learn more: https://bit.ly/3Xa3hB0

Upcoming Changes in Prescription Drugs: What You Need to Know Discover the crucial updates in prescription drug regulations for 2025. We explore the latest rules and potential impacts on your health decisions, ensuring you're prepared for the changes ahead. Don't miss out on this essential information! Watch the full Episode Here https://lnkd.in/e-qNMPBS @Brendan J. McPoyle, CFP®, AEP® #BrendanJMcPoyle#PrescriptionDrugs #HealthUpdates #RegulatoryChanges #2025Forecast #PharmaceuticalNews #HealthcareAwareness #PatientSafety #DrugRegulations #Medications #HealthIndustry

Stop paying for assumptions and start paying for reality with CTRx™. Our innovative solution combines prescription services, global pharmacy dispensing, and centralized local drug supply. CTRx ensures your study only uses the drug needed based on patient enrollment, ultimately eliminating drug waste and bulk supply. Transform your drug supply strategy with CTRx. https://bit.ly/3AdqwRt #ClinicalTrials #DrugSupply #EliminateWaste

Through the #InflationReductionAct Medicare Drug Price Negotiation Program, 10 drugs will now have new, negotiated lower prices, resulting in $1.5 billion in estimated out-of-pocket savings in 2026 for people with Medicare prescription drug coverage. If the new prices had been in effect in 2023, they would have saved Medicare an estimated $6 billion. Learn more: https://lnkd.in/gWdEvMmp